Institutional Profile: The Center for Biomarker Research and Personalized Medicine at Virginia Commonwealth University: advancing psychiatric drug treatment

Personalized Medicine
Joseph L McClay

Abstract

The Center for Biomarker Research and Personalized Medicine is a small, focused and technology-driven organization, sited within the School of Pharmacy on the Medical College of Virginia Campus of Virginia Commonwealth University. The Center was established in 2006, with a mission to improve understanding and treatment of psychiatric disease by employing the latest advances in molecular biology, informatics and statistics. We take the philosophy that large-scale, exploratory studies are crucial to achieve our aims because strong biological associations have been historically absent for psychiatric disorders. Our work follows two main streams: the first being disease biomarker research, such as discovering genes contributing risk for schizophrenia or depression. The second stream is the discovery of biomarkers for therapeutic drug response, where our genome-wide association studies of antipsychotic and antidepressant response have yielded multiple new leads. With the recent success of large-scale biological investigations of psychiatric disorders, we are very optimistic about the future. By engaging cutting-edge technologies such as next-generation DNA sequencing, coupled with biological data integration, we may further probe th...Continue Reading

References

Jun 24, 2000·Nature·A D Roses
May 4, 2004·The American Journal of Psychiatry·Anil K MalhotraJames L Kennedy
Oct 1, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George I Papakostas, Maurizio Fava
Nov 8, 2008·Science·David AltshulerEric S Lander
May 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lucia A HindorffTeri A Manolio
Sep 2, 2009·Molecular Psychiatry·J L McClayE J C G van den Oord
Oct 31, 2009·Biological Psychiatry·Karolina AbergEdwin J C G van den Oord
Mar 3, 2010·Molecular Psychiatry·D E AdkinsE J C G van den Oord
May 19, 2010·Nature Reviews. Genetics·Evan E EichlerJoseph H Nadeau
Jul 14, 2010·Biological Psychiatry·Daniel E AdkinsEdwin J C G van den Oord
Jul 31, 2010·Science·Greg Miller
Oct 6, 2010·The Pharmacogenomics Journal·K AbergE J C G van den Oord
Nov 26, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joseph L McClayEdwin J C G van den Oord
Sep 20, 2011·Nature Genetics·UNKNOWN Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium
Nov 2, 2011·Psychological Medicine·S L ClarkE J C G van den Oord

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Academic Medicine : Journal of the Association of American Medical Colleges
J Messmer
Academic Medicine : Journal of the Association of American Medical Colleges
Alan W DowIsaac K Wood
© 2022 Meta ULC. All rights reserved